Capricor Therapeutics, Inc.
Status: Publicly traded
Direct answer
Capricor Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CAPR.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003,...
Can you invest in Capricor Therapeutics, Inc.?
Yes. Capricor Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CAPR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Capricor Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.